These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 820895)

  • 21. [The immunology of tuberculosis].
    Tokunaga T
    Kekkaku; 1989 Feb; 64(2):121-33. PubMed ID: 2499728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [In vitro studies on the mechanisms of acquired resistance to tuberculous infection (author's transl)].
    Muraoka S
    Fukuoka Igaku Zasshi; 1975 Jun; 66(6):414-28. PubMed ID: 808464
    [No Abstract]   [Full Text] [Related]  

  • 23. Assessment in vitro of immunity against Toxoplasma gondii.
    Jones TC; Len L; Hirsch JG
    J Exp Med; 1975 Feb; 141(2):466-82. PubMed ID: 1113065
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Macrophage turnover, division and activation within developing, peak and "healed" tuberculous lesions produced in rabbits by BCG.
    Dannenberg AM
    Tuberculosis (Edinb); 2003; 83(4):251-60. PubMed ID: 12906836
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cellular immunity in vitro. I. Immunologically mediated enhancement of macrophage bactericidal capacity.
    Simon HB; Sheagren JN
    J Exp Med; 1971 Jun; 133(6):1377-89. PubMed ID: 4102688
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD8+ CTL from lungs of Mycobacterium tuberculosis-infected mice express perforin in vivo and lyse infected macrophages.
    Serbina NV; Liu CC; Scanga CA; Flynn JL
    J Immunol; 2000 Jul; 165(1):353-63. PubMed ID: 10861072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of lymphocyte supernatant fluids on the intracellular growth of virulent tubercle bacilli.
    Klun CL; Youmans GP
    J Reticuloendothel Soc; 1973 Mar; 13(3):263-74. PubMed ID: 4196702
    [No Abstract]   [Full Text] [Related]  

  • 28. Partial characterization of a factor extracted from sensitized lymphocytes that inhibits the growth of Mycobacterium tuberculosis within macrophages in vitro.
    Turcotte R; Des Ormeaux Y; Borduas AG
    Infect Immun; 1976 Aug; 14(2):337-44. PubMed ID: 823109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune functions of murine alveolar macrophages: binding of lymphocytes and support of lymphocyte proliferation.
    Shellito J; Caldwell JL; Kaltreider HB
    Exp Lung Res; 1983 Feb; 4(2):93-107. PubMed ID: 6840048
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition by streptomycin of tubercle bacilli within cultured human macrophages.
    Crowle AJ; Sbarbaro JA; Judson FN; Douvas GS; May MH
    Am Rev Respir Dis; 1984 Nov; 130(5):839-44. PubMed ID: 6437307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune mechanisms in the pathogenesis of pulmonary tuberculosis.
    Dannenberg AM
    Rev Infect Dis; 1989; 11 Suppl 2():S369-78. PubMed ID: 2496453
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Experimental study on the effect of the immune lymphocytes on the growth of tubercle bacilli in macrophages (author's transl)].
    Toyoara M
    Kekkaku; 1977 Jan; 52(1):1-6. PubMed ID: 402495
    [No Abstract]   [Full Text] [Related]  

  • 33. IL-10 converts human dendritic cells into macrophage-like cells with increased antibacterial activity against virulent Mycobacterium tuberculosis.
    Förtsch D; Röllinghoff M; Stenger S
    J Immunol; 2000 Jul; 165(2):978-87. PubMed ID: 10878374
    [TBL] [Abstract][Full Text] [Related]  

  • 34. TLR2 and TLR4 serve distinct roles in the host immune response against Mycobacterium bovis BCG.
    Heldwein KA; Liang MD; Andresen TK; Thomas KE; Marty AM; Cuesta N; Vogel SN; Fenton MJ
    J Leukoc Biol; 2003 Aug; 74(2):277-86. PubMed ID: 12885945
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ribonucleic acid in the immune response.
    Mitsuhashi S; Saito K; Kurashige S; Yamaguchi N
    Mol Cell Biochem; 1978 Aug; 20(3):131-47. PubMed ID: 81465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macrophage-lymphocyte clusters in the immune response to soluble protein antigen in vitro. II. Ultrastructure of clusters formed during the early response.
    Nielsen MH; Jensen H; Braendstrup O; Werdelin O
    J Exp Med; 1974 Nov; 140(5):1260-72. PubMed ID: 4138694
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
    Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
    J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis.
    Oddo M; Renno T; Attinger A; Bakker T; MacDonald HR; Meylan PR
    J Immunol; 1998 Jun; 160(11):5448-54. PubMed ID: 9605147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of cycloheximide on intracellular growth of Mycobacterium leprae in cultured murine macrophages.
    Osawa N
    Kitasato Arch Exp Med; 1991 Dec; 64(4):205-12. PubMed ID: 1823920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Innate inhibition of adaptive immunity: Mycobacterium tuberculosis-induced IL-6 inhibits macrophage responses to IFN-gamma.
    Nagabhushanam V; Solache A; Ting LM; Escaron CJ; Zhang JY; Ernst JD
    J Immunol; 2003 Nov; 171(9):4750-7. PubMed ID: 14568951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.